Combination CPR System Increases Cardiac Blood Flow
By HospiMedica International staff writers Posted on 06 Apr 2015 |
A synergetic cardiopulmonary resuscitation (CPR) system uses two separate devices to improve long-term survival rates by 50%.
The ResQCPR System is based on intrathoracic pressure regulation (IPR), an innovative technology that uses the body’s own mechanisms to enhance circulation, without the use of pharmaceutical or other agents. The system comprises of two devices, the ResQPOD impedance threshold device and the ResQPUMP active compression-decompression CPR Device, which work together in synergy to improve perfusion. As the chest wall recoils, the vacuum in the thorax is enhanced, more than doubling blood flow during CPR. The mechanism increases cardiac output, blood pressure, and survival rates.
The ResQPOD inspiratory impedance threshold device is based on a valve inside the mask that improves venous return to the heart. The mask is placed over the mouth, helping to properly move air in and out of the lungs and increase blood flow to the heart and the brain, thus effectively raising the chances of survival while reducing the possibility of neurological damage. The ResQCPR System is a product of ZOLL Medical Corporation (ZOLL; Chelmsford, MA, USA), developed by Advanced Circulatory Systems (ACS; Roseville, MN, USA).
“The ResQCPR System is a huge advance in the treatment of cardiac arrest and we look forward to working with clinicians and rescuers around the country to implement this new system of care to increase the likelihood of survival from cardiac arrest and the potential to return patients to a full life after critical medical emergencies,” said Mike Black, president of ACS, now part of ZOLL. “This technology demonstrates ZOLL’s commitment to offering the most comprehensive portfolio of products for acute events.”
An inspiratory impedance threshold valve enhances the return of blood to the thorax during the decompression phase of CPR, resulting in a greater negative intrathoracic pressure during chest wall decompression. This leads to improved vital organ perfusion during both standard and active compression-decompression (ACD) CPR. It works by harnessing the kinetic energy of the outward movement of the chest wall during CPR. When used in conjunction with ACD CPR, the addition of the impedance valve results in sustained systolic blood pressures greater than 100 mmHg and diastolic pressures greater than 55 mmHg.
Related Links:
ZOLL Medical Corporation
Advanced Circulatory Systems
The ResQCPR System is based on intrathoracic pressure regulation (IPR), an innovative technology that uses the body’s own mechanisms to enhance circulation, without the use of pharmaceutical or other agents. The system comprises of two devices, the ResQPOD impedance threshold device and the ResQPUMP active compression-decompression CPR Device, which work together in synergy to improve perfusion. As the chest wall recoils, the vacuum in the thorax is enhanced, more than doubling blood flow during CPR. The mechanism increases cardiac output, blood pressure, and survival rates.
The ResQPOD inspiratory impedance threshold device is based on a valve inside the mask that improves venous return to the heart. The mask is placed over the mouth, helping to properly move air in and out of the lungs and increase blood flow to the heart and the brain, thus effectively raising the chances of survival while reducing the possibility of neurological damage. The ResQCPR System is a product of ZOLL Medical Corporation (ZOLL; Chelmsford, MA, USA), developed by Advanced Circulatory Systems (ACS; Roseville, MN, USA).
“The ResQCPR System is a huge advance in the treatment of cardiac arrest and we look forward to working with clinicians and rescuers around the country to implement this new system of care to increase the likelihood of survival from cardiac arrest and the potential to return patients to a full life after critical medical emergencies,” said Mike Black, president of ACS, now part of ZOLL. “This technology demonstrates ZOLL’s commitment to offering the most comprehensive portfolio of products for acute events.”
An inspiratory impedance threshold valve enhances the return of blood to the thorax during the decompression phase of CPR, resulting in a greater negative intrathoracic pressure during chest wall decompression. This leads to improved vital organ perfusion during both standard and active compression-decompression (ACD) CPR. It works by harnessing the kinetic energy of the outward movement of the chest wall during CPR. When used in conjunction with ACD CPR, the addition of the impedance valve results in sustained systolic blood pressures greater than 100 mmHg and diastolic pressures greater than 55 mmHg.
Related Links:
ZOLL Medical Corporation
Advanced Circulatory Systems
Read the full article by registering today, it's FREE!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
- Free digital version edition of HospiMedica International sent by email on regular basis
- Free print version of HospiMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of HospiMedica International in digital format
- Free HospiMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergecny Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure